These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24314202)

  • 1. Inhibition of synovitis and joint destruction by a new single domain antibody specific for cyclophilin A in two different mouse models of rheumatoid arthritis.
    Wang L; Jia J; Wang C; Ma X; Liao C; Fu Z; Wang B; Yang X; Zhu P; Li Y; Chen Z
    Arthritis Res Ther; 2013; 15(6):R208. PubMed ID: 24314202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway.
    Wang Q; Zhou X; Zhao Y; Xiao J; Lu Y; Shi Q; Wang Y; Wang H; Liang Q
    Front Immunol; 2018; 9():2091. PubMed ID: 30319603
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.
    Yang Y; Lu N; Zhou J; Chen ZN; Zhu P
    Rheumatology (Oxford); 2008 Sep; 47(9):1299-310. PubMed ID: 18567920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis.
    Wang L; Wang CH; Jia JF; Ma XK; Li Y; Zhu HB; Tang H; Chen ZN; Zhu P
    J Clin Immunol; 2010 Jan; 30(1):24-33. PubMed ID: 19789967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophilin A Aggravates Collagen-Induced Arthritis via Promoting Classically Activated Macrophages.
    Dongsheng Z; Zhiguang F; Junfeng J; Zifan L; Li W
    Inflammation; 2017 Oct; 40(5):1761-1772. PubMed ID: 28756520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
    Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages.
    Kim H; Kim WJ; Jeon ST; Koh EM; Cha HS; Ahn KS; Lee WH
    Clin Immunol; 2005 Sep; 116(3):217-24. PubMed ID: 15993649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Anti-Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental Arthritis.
    Hoshino-Negishi K; Ohkuro M; Nakatani T; Kuboi Y; Nishimura M; Ida Y; Kakuta J; Hamaguchi A; Kumai M; Kamisako T; Sugiyama F; Ikeda W; Ishii N; Yasuda N; Imai T
    Arthritis Rheumatol; 2019 Feb; 71(2):222-231. PubMed ID: 30079992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis.
    Jia J; Wang C; Shi Z; Zhao J; Jia Y; Zhao-Hui Z; Li X; Chen Z; Zhu P
    Rheumatology (Oxford); 2009 Jul; 48(7):721-6. PubMed ID: 19429906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SND-117, a sinomenine bivalent alleviates type II collagen-induced arthritis in mice.
    Zhou YR; Zhao Y; Bao BH; Li JX
    Int Immunopharmacol; 2015 Jun; 26(2):423-31. PubMed ID: 25887268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
    Matsuno H; Sawai T; Nezuka T; Uzuki M; Tsuji H; Nishimoto N; Yoshizaki K
    Arthritis Rheum; 1998 Nov; 41(11):2014-21. PubMed ID: 9811057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage.
    Xie C; Ma L; Liu J; Li X; Pei H; Xiang M; Chen L
    PLoS One; 2013; 8(2):e56349. PubMed ID: 23431370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of Oroxylin A in rheumatoid arthritis.
    Wang YL; Gao JM; Xing LZ
    Int Immunopharmacol; 2016 Nov; 40():294-299. PubMed ID: 27643663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.
    Guo C; Fu R; Wang S; Huang Y; Li X; Zhou M; Zhao J; Yang N
    Clin Exp Immunol; 2018 Nov; 194(2):231-243. PubMed ID: 30277570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.